Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy

Published:2010-07-15 Issue:11 Volume:24 Page:4535-4544
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Huijbers Elisabeth J. M.¹,Ringvall Maria¹,Femel Julia¹,Kalamajski Sebastian¹,Lukinius Agneta²,Åbrink Magnus¹,Hellman Lars³,Olsson Anna‐Karin¹

Affiliation:

1. Department of Medical Biochemistry and MicrobiologyBiomedical Center Uppsala Sweden

2. Department of Genetics and PathologyRudbeck LaboratoryUppsala University Uppsala Sweden

3. Department of Cell and Molecular BiologyBiomedical Center Uppsala Sweden

Funder

Vetenskapsrådet

Cancerfonden

Svenska Läkaresällskapet

Jeanssons Stiftelser

Åke Wiberg Stiftelse

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.10-163022

Reference31 articles.

1. Therapeutic vaccines against IgE-mediated allergies

2. Human embryo immune escape mechanisms rediscovered by the tumor

3. Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine

4. Generation of therapeutic antibody responses against IgE through vaccination

5. Tumour vascular targeting

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoantigens in cancer immunotherapy: focusing on alternative splicing;Frontiers in Immunology;2024-07-11

2. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy;Cell Death & Disease;2024-05-01

3. CAR-T Therapy Targets Extra Domain B of Fibronectin Positive Solid Tumor Cells;Immunological Investigations;2023-10-10

4. Targeting alternative splicing in cancer immunotherapy;Frontiers in Cell and Developmental Biology;2023-08-10

5. Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned Dogs;Cancers;2023-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3